Tarptautinis bioterapijos institutas, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
0.00 |
- |
- |
2,500 |
0 |
0 |
2,500 |
2023 |
---|
0 |
- |
-3,930 |
-3,930 |
- |
- |
-1.05 |
- |
- |
-1,430 |
1,500 |
0 |
70 |
2024 |
---|
113,081 |
37,694 |
12,226 |
10,974 |
3,658 |
0.08 |
4.82 |
33.38 |
9.70 |
9,544 |
45,981 |
0 |
59,944 |
Register and
explore Okredo data2024 |
---|
113,081 |
37,694 |
12,226 |
10,974 |
3,658 |
0.08 |
4.82 |
33.38 |
9.70 |
9,544 |
45,981 |
0 |
59,944 |
Register and
explore Okredo data2024
Turnover (€)
113,081 €- *
Sales per employee (€)
37,694 €- *
Profit before tax (€)
12,226 €411 % *
Net Profit (€)
10,974 €379 % *
Profit per employee (€)
3,658 €- *
Working capital requirement
0.08 - *
Debt-to-equity ratio
4.82 559.05 % *
Total profitability (%)
33.38 %- *
Net profitability (%)
9.70 %- *
Equity (€)
9,544 €767 % *
Amounts Payable And Liabilities (€)
45,981 €2,965 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
59,944 €85,534 % *